{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T10:46:06Z","timestamp":1785321966743,"version":"3.55.0"},"reference-count":8,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,3,31]],"date-time":"2025-03-31T00:00:00Z","timestamp":1743379200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>The Paris 2024 Olympic and Paralympic Games posed logistical challenges for healthcare delivery, particularly for maintaining home-based cancer treatments amidst road closures and 15 million visitors. The Hospital at Home (HaH) program of Greater Paris University Hospitals (AP-HP) implemented innovative strategies to ensure uninterrupted care during this period.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>HaH deployed a \u201cGames Pass\u201d system for its fleet of 500 vehicles and introduced electric bicycles and optimized pedestrian routes to address accessibility constraints. Dedicated lanes, in collaboration with city officials, ensured timely care. Personalized care plans were developed, accounting for patient locations and event schedules. Drug preparation was centralized, and advanced cold-chain methods facilitated delivery. Strategic pre-positioning of vehicles and personnel within restricted zones ensured continuous care, supported by real-time coordination through a dedicated management team.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Between July 26 and September 8, 2024, HaH administered 1,946 chemotherapy\/immunotherapy sessions to 535 patients (median age 72, IQR 60\u201379), including 29 pediatric cases. This represented 4.76% of AP-HP\u2019s total treated cancer patients, a significant increase from 2023 (3.9%, <jats:italic>p<\/jats:italic> &amp;lt;\u202f0.05). Treatments included 31 drugs, with azacitidine (<jats:italic>n<\/jats:italic> =\u202f1,025) and daratumumab (<jats:italic>n<\/jats:italic> =\u202f248) being most common. Key indications were multiple myeloma (<jats:italic>n<\/jats:italic> =\u202f235) and myeloid neoplasms (<jats:italic>n<\/jats:italic> =\u202f175). No treatment delays or patient harm were reported.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>The HaH program ensured continuity of care during the Games, highlighting the importance of flexibility, real-time problem-solving, and patient-centered planning. These strategies offer valuable insights for improving routine HaH operations and managing healthcare during large-scale events.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fmed.2025.1560027","type":"journal-article","created":{"date-parts":[[2025,3,31]],"date-time":"2025-03-31T05:36:44Z","timestamp":1743399404000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Cancer care delivery during the Paris 2024 Olympic and Paralympic games: lessons from a crisis-driven Hospital at Home program"],"prefix":"10.3389","volume":"12","author":[{"given":"Jeremie","family":"Zerbit","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecile","family":"Chauvin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arsene","family":"Zogo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Avran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederique","family":"Moufle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florent","family":"Bousquie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clement","family":"Leclaire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,3,31]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1016\/S0140-6736(20)31210-1","article-title":"Assistance Publique\u2013H\u00f4pitaux de Paris\u2019 response to the COVID-19 pandemic","volume":"395","year":"2020","journal-title":"Lancet"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"2535","DOI":"10.1016\/S0140-6736(15)01063-6","article-title":"The medical response to multisite terrorist attacks in Paris","volume":"386","author":"Hirsch","year":"2015","journal-title":"Lancet"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1136\/spcare-2023-004385","article-title":"Home emergency response team for the seriously ill palliative care patient: feasibility and effectiveness","volume":"14","author":"Deniau","year":"2024","journal-title":"BMJ Support Palliat Care"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"2242","DOI":"10.1002\/cam4.3682","article-title":"COVID-19 outbreak: an experience to reappraise the role of Hospital at Home in the anti-cancer drug injection","volume":"10","author":"Mittaine-Marzac","year":"2021","journal-title":"Cancer Med"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"570","DOI":"10.3322\/caac.21727","article-title":"Oncologic emergencies and urgencies: a comprehensive review","volume":"72","author":"Gould Rothberg","year":"2022","journal-title":"CA Cancer J Clin"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1097\/JTO.0b013e31824afc55","article-title":"What is the most effective follow-up model for lung cancer patients? A systematic review","volume":"7","author":"Schmidt-Hansen","year":"2012","journal-title":"J Thorac Oncol Off Publ Int Assoc Study Lung Cancer"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1186\/s12885-022-09461-z","article-title":"Supportive oncology care at home interventions: protocols for clinical trials to shift the paradigm of care for patients with cancer","volume":"22","author":"Nipp","year":"2022","journal-title":"BMC Cancer"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"7000","DOI":"10.1200\/JCO.2020.38.15_suppl.7000","article-title":"The oncology Hospital at Home: health care utilization outcomes from the huntsman at home trial","volume":"38","author":"Mooney","year":"2020","journal-title":"J Clin Oncol"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1560027\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,31]],"date-time":"2025-03-31T05:36:45Z","timestamp":1743399405000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1560027\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,31]]},"references-count":8,"alternative-id":["10.3389\/fmed.2025.1560027"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2025.1560027","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,31]]},"article-number":"1560027"}}